ACCESSION: MSBNK-SMB_Measured-HSA015P0306001
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 12
COMMENT: RAW_SPEC {'EL03_pos_6418': {'bp': 586962.0, 'sum': 2178784.0}, 'EL03_pos_6058': {'bp': 544349.0, 'sum': 2188048.0}, 'EL03_pos_6227': {'bp': 542670.0, 'sum': 2163984.0}, 'EL05_pos_6406': {'bp': 22822.0, 'sum': 93186.0}, 'EL01_pos_6034': {'bp': 21817.0, 'sum': 91340.0}, 'EL07_pos_6369': {'bp': 21453.0, 'sum': 77047.0}, 'EL04_pos_6388': {'bp': 19966.0, 'sum': 84587.0}, 'EL05_pos_6065': {'bp': 19812.0, 'sum': 80543.0}, 'EL04_pos_6023': {'bp': 18241.0, 'sum': 70021.0}, 'EL07_pos_6023': {'bp': 17411.0, 'sum': 70956.0}, 'EL06_pos_6407': {'bp': 15869.0, 'sum': 68084.0}, 'EL02_pos_6077': {'bp': 14186.0, 'sum': 67089.0}}
COMMENT: RETENTION_TIME_STDEV 0.294
COMMENT: PRECURSOR_M/Z_RAW 306.191083
COMMENT: PRECURSOR_M/Z_STDEV 0.000093
COMMENT: PRECURSOR_IN_MS1 mz 306.191075; int 47.908; delta(ppm) 1.324649
COMMENT: PROPOSED_CHARGE_STATE +1; mz 307.194264; int 8.246; cor 0.782
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 4.505; C15H23N5O2; [M+H]+; delta(ppm) -4.505482
COMMENT: PROPOSED_MF SevenGoldenRules 0.125; C14H27NO6; [M+H]+; delta(ppm) -0.124515
COMMENT: PROPOSED_MF MS-FINDER 2.815; C14H27NO6; [M+H]+; delta(ppm) -0.124212
COMMENT: PROPOSED_MF MS-FINDER 2.186; C15H23N5O2; [M+H]+; delta(ppm) -4.492098
COMMENT: PROPOSED_MF MS-FINDER 1.853; C7H27N7O4S; [M+H]+; delta(ppm) -2.363986
COMMENT: PROPOSED_MF MS-FINDER 1.769; C15H31NOS2; [M+H]+; delta(ppm) -2.962358
COMMENT: PROPOSED_MF MS-FINDER 1.691; C11H19N11; [M+H]+; delta(ppm) 4.278003
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.097; C17H27NO2Si; [M+H]+; delta(ppm) -172752.852375
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.994; C14H31NO2SSi; [M+H]+; delta(ppm) -172760.386785
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.839; C14H28FNO3Si; [M+H]+; delta(ppm) -172755.406202
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.612; C16H27BO3Si; [M+H]+; delta(ppm) -149762.957543
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.446; C11H27BN2O5Si; [M+H]+; delta(ppm) -149753.459930
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.238; C18H27NOS; [M+H]+; delta(ppm) 8.047580
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.000; C15H23N5O2; [M+H]+; delta(ppm) -4.492098
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.000; C14H27NO6; [M+H]+; delta(ppm) -0.124212
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.986; C10H23N7O4; [M+H]+; delta(ppm) 8.645966
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.743; C15H31NOS2; [M+H]+; delta(ppm) -2.962358
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.480; C17H27NO2Si; [M+H]+; delta(ppm) -172752.852375
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.168; C14H31NO2SSi; [M+H]+; delta(ppm) -172760.386785
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.138; C14H28FNO3Si; [M+H]+; delta(ppm) -172755.406202
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.118; C16H27BO3Si; [M+H]+; delta(ppm) -149762.957543
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.096; C11H27BN2O5Si; [M+H]+; delta(ppm) -149753.459930
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; YXBQLONCIPUQKO-LGNMMBHFNA-N; [M+H]+; CN(C)CCCO[C@H]1[C@@H](O[C@@H]2OC(C)(C)O[C@@H]12)[C@H](O)CO
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; ZSKWGPHHNZAZRB-DFLITBPSNA-N; [M+H]+; CO[C@@H]1C[C@@H](O)[C@@H](O[C@H]2C[C@](C)(N)[C@@H](O)[C@H](C)O2)[C@H](C)O1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; DJNMJQSJOBIZTO-UHFFFAOYSA-N; [M+H]+; O=C(NC1C(OCCCC)OC(CO)C(OC)C1OC)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; ALAAMLURECZPNW-UHFFFAOYSA-N; [M+H]+; O=C(NC1CC1)C2CN3CCC2CC3CN4N=NC(=C4)CO
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; BAVOZGLBLHUQAP-UHFFFAOYSA-N; [M+H]+; O=C(N1CC2N(CCOC2)C3(C1)CN(CC4=CN=CN4)C3)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.221; YXBQLONCIPUQKO-LGNMMBHFNA-N; [M+H]+; (1R)-1-[(3aR,5S,6S,6aS)-6-[3-(dimethylamino)propoxy]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethane-1,2-diol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.169; ZSKWGPHHNZAZRB-DFLITBPSNA-N; [M+H]+; UNPD114521
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.117; DJNMJQSJOBIZTO-UHFFFAOYSA-N; [M+H]+; N-[2-butoxy-6-(hydroxymethyl)-4,5-dimethoxyoxan-3-yl]acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.488; ALAAMLURECZPNW-UHFFFAOYSA-N; [M+H]+; N-cyclopropyl-6-{[4-(hydroxymethyl)-1H-1,2,3-triazol-1-yl]methyl}-1-azabicyclo[2.2.2]octane-3-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.488; BAVOZGLBLHUQAP-UHFFFAOYSA-N; [M+H]+; 1-{1-[(1H-imidazol-5-yl)methyl]-hexahydro-1'H-spiro[azetidine-3,6'-pyrazino[2,1-c][1,4]oxazin]-8'-yl}ethan-1-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.488; FMOHRHZYUWIUEQ-UHFFFAOYSA-N; [M+H]+; N'-[(octahydro-1H-quinolizin-1-yl)methyl]-N-(1H-pyrazol-5-yl)ethanediamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; BAVOZGLBLHUQAP-UHFFFAOYSA-N; [M+H]+; 1-{1-[(1H-imidazol-5-yl)methyl]-hexahydro-1'H-spiro[azetidine-3,6'-pyrazino[2,1-c][1,4]oxazin]-8'-yl}ethan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; DJNMJQSJOBIZTO-UHFFFAOYSA-N; [M+H]+; N-[2-butoxy-6-(hydroxymethyl)-4,5-dimethoxyoxan-3-yl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.948; FMOHRHZYUWIUEQ-UHFFFAOYSA-N; [M+H]+; N'-[(octahydro-1H-quinolizin-1-yl)methyl]-N-(1H-pyrazol-5-yl)ethanediamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.807; ALAAMLURECZPNW-UHFFFAOYSA-N; [M+H]+; N-cyclopropyl-6-{[4-(hydroxymethyl)-1H-1,2,3-triazol-1-yl]methyl}-1-azabicyclo[2.2.2]octane-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.561; ZSKWGPHHNZAZRB-DFLITBPSNA-N; [M+H]+; UNPD114521
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; YXBQLONCIPUQKO-LGNMMBHFNA-N; [M+H]+; (1R)-1-[(3aR,5S,6S,6aS)-6-[3-(dimethylamino)propoxy]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethane-1,2-diol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; YXBQLONCIPUQKO-UJPOAAIJSA-N; [M+H]+; (1R)-1-[(3aR,5R,6S,6aR)-6-[3-(dimethylamino)propoxy]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethane-1,2-diol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; HXXZUIZPSOFUMY-UHFFFAOYSA-N; [M+H]+; 7-[2-(cyclohexylamino)ethyl]-1,3-dimethylpurine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.973; UGNWSQQWYJSJLO-FGWVZKOKSA-N; [M+H]+; 2-amino-N-[(1S,5R)-8-ethyl-8-azabicyclo[3.2.1]octan-3-yl]-4-methoxypyrimidine-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; LTAGBZVDISPAGQ-UHFFFAOYSA-N; [M+H]+; 2-[5-(3,4-dimethoxyphenyl)tetrazol-2-yl]-N,N-diethylethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -163.098; BZIUQEWEZHJBSY; [M+H]+; (NZ,S)-N-[4-[tert-butyl(dimethyl)silyl]oxybutylidene]-2-methylpropane-2-sulfinamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -163.165; POGOBGDWUNVVKD; [M+H]+; (NE,R)-N-[4-[tert-butyl(dimethyl)silyl]oxybutan-2-ylidene]-2-methylpropane-2-sulfinamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -168.160; LYWXLNZTROQRSS; [M+H]+; (S)-N-((S)-1-((tert-Butyldimethylsilyl)oxy)but-3-en-2-yl)-2-methylpropane-2-sulfinamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -174.424; ISJQPKNQLUAPTB; [M+H]+; [3-[Tert-butyl(dimethyl)silyl]-5-methyl-2-prop-2-enoxyphenyl]boronic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -175.660; PHRVIUIAVNHLQY; [M+H]+; N-[3-[tert-butyl(dimethyl)silyl]oxypropylidene]-3-methylbutane-2-sulfinamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -179.068; KNBIODRKQRCPAO; [M+H]+; (3-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-YL)phenyl)trimethylsilane
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -184.172; HHSNBYWXVXONAM; [M+H]+; (NE,R)-N-[3-[tert-butyl(dimethyl)silyl]oxybutylidene]-2-methylpropane-2-sulfinamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -193.328; IAVYRVUZPCCYPJ; [M+H]+; 2-[(S)-Phenyl[(trimethylsilyl)oxy]methyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -194.848; SLAMDQXGEJRELN; [M+H]+; N-[1-cyclopropyl-2-[dimethyl(propan-2-yloxy)silyl]ethyl]-2-methylpropane-2-sulfinamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -197.485; PNQWWKLROVSCMF; [M+H]+; N-[2-(1,1-dioxothiolan-3-yl)-3-trimethylsilylpropyl]-2-methylpropan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.002; BZIUQEWEZHJBSY; [M+H]+; (NZ,S)-N-[4-[tert-butyl(dimethyl)silyl]oxybutylidene]-2-methylpropane-2-sulfinamide
COMMENT: CONFIDENCE Level 5: Exact mass of interest 306.191076; Observed in MS1; Charge state +1;
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 10.089
MS$FOCUSED_ION: PRECURSOR_M/Z 306.191076
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0550-9040000000-27fd7379eef259e099b6
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  59.0313788 598.6031 ? 59.032103 0.8470 132.25 1.0000 12
  61.0106201 264.8936 ? 61.011350 1.0654 37.34 0.6294 12
  75.0261866 443.3916 ? 75.026927 0.6798 91.79 0.7622 12
  77.0418157 447.8270 ? 77.042552 0.5971 63.33 0.6434 12
  93.0366023 274.9533 ? 93.037269 0.9674 90.61 0.4895 12
  285.0727078 999.0000 ? 285.073106 0.8033 0.00 0.6503 12
PK$NUM_PEAK: 6
PK$PEAK: m/z int. rel.int.
  59.031379 598.60 598
  61.010620 264.89 264
  75.026187 443.39 443
  77.041816 447.83 447
  93.036602 274.95 274
  285.072708 999.00 999
//
